文献速递睡眠呼吸障碍

持续气道正压对成人阻塞性睡眠呼吸暂停神经影像生物标志物及认知的影响:一项随机对照试验

Effects of Continuous Positive Airway Pressure on Neuroimaging Biomarkers and Cognition in Adult Obstructive Sleep Apnea: A Randomized Controlled Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

本研究为多中心随机对照试验,纳入148例认知正常且呼吸暂停低通气指数≥15/h的成人OSA患者,随机分为CPAP联合最佳支持治疗组与单独BSC组,评估12个月CPAP对神经影像生物标志物和认知的影响。主要终点6个月MoCA评分两组无显著差异,但CPAP组默认模式网络功能连接和皮层厚度有显著改善,无严重不良事件。

要点

  • CPAP未改善6个月MoCA评分,但可改善默认模式网络功能连接和皮层厚度。
  • 认知正常的OSA患者早期CPAP治疗可能逆转脑萎缩过程。
  • CPAP治疗未发生严重不良事件。

核心结论

  • CPAP改善皮层厚度和默认模式网络功能连接,提示OSA患者经CPAP治疗可能从脑萎缩过程中恢复;但MoCA评分未见改善。

研究设计与样本

  • 多中心随机临床试验,纳入148例认知正常且呼吸暂停低通气指数≥15/h的成人OSA患者,随机分为CPAP联合最佳支持治疗组和单独BSC组,评估12个月CPAP效果。

主要发现

  • 6个月时CPAP组与BSC组MoCA评分差异无统计学意义(差值-0.04;95%CI -0.72至0.65;P=0.91)。
  • 6个月时CPAP组与BSC组默认模式网络功能连接有显著差异(差值-13.73;95%CI -23.40至-4.06;P=0.01)。
  • 6个月时CPAP组与BSC组皮层厚度有显著差异(差值-0.06 mm;95%CI -0.10至-0.01 mm;P=0.02)。
  • 未发生严重不良事件。

临床怎么用

  • 对认知正常的中重度OSA患者,CPAP治疗可能有助于改善脑结构和功能,但不应期望短期内提升MoCA评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Obstructive sleep apnea (OSA) is associated with cognitive impairment. The effects of continuous positive airway pressure (CPAP) on neuroimaging biomarkers and cognitive performance among middle-aged patients with OSA and normal cognition remain unclear. Objectives: To investigate the effects of CPAP therapy over 12 months on neuroimaging biomarkers and cognitive performance. Methods: In this multicenter, randomized clinical trial, we randomly assigned 148 participants with normal cognition and an apnea-hypopnea index ⩾15/h into two groups: patients receiving CPAP with best supportive care (BSC); and patients receiving BSC alone. The primary endpoint was Montreal Cognitive Assessment (MoCA) score at 6 months after enrollment. The secondary endpoints were intranetwork functional connectivity (FC) of default mode network (DMN) and cortical thickness assessed by functional and structural magnetic resonance imaging, other neuroimaging biomarkers, and neurobehavioral tests. Measurements and Main Results: Between 2017 and 2021, 148 patients were recruited from five hospitals. Linear mixed models showed that there was no significant difference in MoCA scores at 6 months between the CPAP and BSC groups (difference, -0.04; 95% confidence interval [CI], -0.72 to 0.65; P = 0.91). However, there were significant differences in the FC of DMN (difference, -13.73; 95% CI, -23.40 to -4.06; P = 0.01) and cortical thickness (difference, -0.06 mm; 95% CI, -0.10 to -0.01 mm; P = 0.02) between CPAP and BSC groups at 6 months after treatment. No serious adverse events occurred. Conclusions: CPAP improved cortical thickness and FC of DMN, suggesting that patients with OSA may recover from brain atrophic processes after CPAP treatment. However, no improvement in MoCA was found. Clinical trial registered with www.clinicaltrials.gov (NCT02886156).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Xu H, Liu Y, Li C, et al. Effects of Continuous Positive Airway Pressure on Neuroimaging Biomarkers and Cognition in Adult Obstructive Sleep Apnea: A Randomized Controlled Trial. Am J Respir Crit Care Med. 2025. PMID: 39998447. doi:10.1164/rccm.202406-1170OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。